Dual-Use Panel
The same panel for both FFPE tissue and liquid biopsy samples.
Oncology 188-Gene Variant Assay
The Preferred Choice for Precision Oncology Medication
Oncology 188-Gene Variant Assay
The Oncology 188-Gene Variant Assay is a qualitative in vitro diagnostic assay that uses hybrid capture-based next-generation sequencing (NGS) to detect variants in 188 tumor-related genes from both FFPE tissue and liquid biopsy samples, enabling personalized treatment decisions for multiple solid tumor types. The assay detects single nucleotide variants (SNVs), insertions and deletions (InDels), gene rearrangements and fusions, copy number variations (CNVs), and microsatellite instability (MSI) status.
Low DNA Input
FFPE tissue ≥30 ng; ctDNA ≥15 ng.
High Sensitivity (LoD)
2% VAF for FFPE tissue and 0.2% VAF for liquid biopsy (hotspot).
Workflow Flexibility
Automation and manual workflows available per your needs
Rapid, Automated Workflow
Turn-around time (TAT) as short as 24 hours from sample to report.